Non Alcoholic Fatty Liver. Fatty (change of) liver, not elsewhere classified
Conditions
Interventions
Intervention 1: Group A: received medication (Rocaltrol) capsules (soft gel) 1mcg/day. Intervention 2: Group B: received medication (vitD3) capsules (soft gel) 50000IU/week. Intervention 3: Group C: c
Treatment - Drugs
Group A: received medication (Rocaltrol) capsules (soft gel) 1mcg/day
Group B: received medication (vitD3) capsules (soft gel) 50000IU/week
Group C: control
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: The study inclusion criteria: the patients by NAFLD (non-alcoholic fatty liver disease) definition; age>18 years old; patient's cooperation. The study exclusion criteria: any liver disease except for NAFLD; alcohol consumption and any addictive drugs; lactating or pregnant patients; noncooperation or dissatisfaction of the patient; any drug consumption that may affect NAFLD.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Vit D. Timepoint: Before intervention and 2 month after it. Method of measurement: Blood test.;ALT. Timepoint: Before intervention and 2 month after it. Method of measurement: Blood Test.;AST. Timepoint: Befor intervention and 2 month after it. Method of measurement: Blood test.;Lipid profile. Timepoint: Befor intervention and 2 month after it. Method of measurement: Blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Laleh Mahmoudi
Shiraz School of Pharmacy
Outcome results
None listed